Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Low volume pushing down. A bit of covering and repeat. Typical! Approved then high volume boom!!!
I notice you had no interest here untill they submitted for approval. Why now the sudden interest and serious attention? Very curious!
I looked around a little, and it does appear that there is cautious optimism that the outbreak is slowing down. For instance, the following:
https://www.webmd.com/a-to-z-guides/news/20220829/us-monkeypox-outbreak-may-be-slowing
But the reason is not that the virus itself is dying out; it's because of more robust medical intervention, mainly in the form of vaccines and educational efforts to modify behaviors within more vulnerable populations.
This means, IMO, that health resources will be sure to seize on any tool that emerges to continue this trend. An effective PCR will definitely find an eager market. All IMO.
"The monkeypox outbreak is showing signs of slowing in the big US cities, thus the waning interest for monkeypox stocks"
It's hard to know for sure if the actual data shows that the outbreak is slowing down. The media hype shifted when the FBI raided Mar-a-Lago, so we've been hearing less about the previous hype-de-jour, monkeypox.
We'll have to see what unfolds here. All JMO, of course.
Nice. Thanks for sharing that.
The shares you own at half price will be half price soon enough
I look at it this way. When the Covid pandemic became a pandemic and there was a mad scramble to produce a vaccine, the two winners turned out to be Pfizer and Moderna. There were lots of wannabes at the beginning. None were actually capable of producing a vaccine but the PRs they put out sure made it seem that way.
In the aftermath, the wannabes have lost anywhere from 50 to 95 percent of market value.
I think this is the situation with Applied DNA.
So you agree with me?
Doubt that. The monkeypox outbreak is showing signs of slowing in the big US cities, thus the waning interest for monkeypox stocks
Where will the chart be charting in 10 days? Under a buck? Thrill is always gone with this stock
You like to speak of "on low volume" think about what the majority of shares are owned at. I own mine at half that price. I will continue to buy at low volume deals of a life time. The only thing that could f me is not getting approved. I am confident we will certainly get approved. If you have enough powder well all of the shares I own now may be a push. All of the shares I buy next week will make me money. We will get approved and then the chase is on. My only issue is if I sell before the top. I do that way to often. Shame on me.
No doubt, gonna be crazy wild imo
Picked up 530 more shares today . Up to 1730 shares. Come on approval. This will move fast.
Imo we the biggest player…love seeing low volume take down, means only one thing, volume on news with them short covers under $5, they likely made bank in the 5/6’s
Today's buy was set by watching trades yesterday and I held firm at 3.38 I will buy more but at like 3.32 or I am good where I sit at 3.45 Ave. Sell.........not untill "APPROVED"
I am sitting on 1,200 shares. I will not miss out on approved!!!!!. I will absolutely quadruple my position here if people sell lower. Come on short me baby!
Bids not getting filled to fast. Good sign for bottom before blast off.
Thanks for the followup..looking for this week.
I emailed the Company this afternoon, asking if they had any sense from the NYS Health Department when to expect a reply to their PCR application.
I received a reply pretty quickly:
"Hello -
New York State Department of Health offered no guidance on a timeline for its decision to either approve or refuse our diagnostic. What they have communicated to us is that all monkeypox virus-related submissions are being expedited, however, they did not define 'expedited.' "
(emphasis added)
Yes..important to remember we manufacture/distribute..not just license technology.
That's a very important point - thanks for pointing it out.
I wonder what their capacity is to produce the kits. Can they match the demand if this thing really begins to spread?
However…they’re-the-test-kit-manufacturer(supply control strategy):“Moreover, as the test kit manufacturer, we maximize the control over our own supply chain to ensure both quality and availability." https://www.businesswire.com/news/home/20220819005040/en/Applied-DNA-Submits-PCR-based-Monkeypox-Virus-Diagnostic-Test-for-Approval-to-New-York-State-Department-of-Health
Now we’re getting somewhere
Unfortunately not odd at all. Still waiting for the press release where they say they are changing their business model for the third time. whatever happened to the dna tagging business I invested in?
I received this clarification email today:
Hello -
In response to your question below, on the assumption that we secure approval for our monkeypox virus test as an LDT from the New York State Department of Health (NYSDOH), our sales strategy is for our clinical lab subsidiary to serve as a reference lab to hospital systems and larger clinical labs in New York State, as well as clinical labs located in other States that allow sample processing by clinical labs permitted under the New York State Department of Health Clinical Laboratory Evaluation Program (CLEP), currently approximately 46 states nationwide. Any samples collected from NYS or another state under CLEP-permittance can only be processed in our clinical lab in N.Y.
We have experience in this model this year as we served as a reference lab for COVID-19 testing, for which we utilize an internally-developed diagnostic test conditionally approved as an LDT by NYSDOH. If approved, our monkeypox test would follow the same path to market.
Given this, we have no current plans to seek FDA approval for this diagnostic. To be precise, we are not a diagnostics manufacturer. Rather, we are a testing services provider that has developed a PCR-based test that requires a workflow that is unique to our clinical lab and leverages the established workflow for our COVID-19 testing service. This then makes the LDT regulatory path the optimal one for us.
We offered a deeper discussion into this diagnostic's path to market on our quarterly investor call last week, which you can access here: https://investors.adnas.com/news-events/company-events/
Huge production undertaking..would like require co-op/acquisition/production expansion.
What I’n thinking about is licensing the test out to a company like Labcorp, so anyone anywhere can walk in and get tested.
Little odd that they would choose to publicize this on a Friday afternoon, especially in the summer, rather than waiting till Monday morning, the beginning of a fresh trading week. Oh well...
First come first serve industry
All about capacity..even the best can’t handle 100% market in shortest period of time.
Is there any move underway, once approved, to get this test out beyond NYC to the rest of the country?
Exactly why holding through volatility counts.
It's now a week since the Q3 report. The CEO said that they would be providing New York State with the final version of the PCR tests "in two weeks, if not sooner".
That IMO is the next possible trigger to watch for. If there is genuine concern about the growing spread of monkeypox, and testing is lagging, this will be a big step.
As someone noted here earlier, it is not very pleasant to be "looking forward" to other people's misery just to make a couple of bucks... but the misery is there already, and this could actually minimize it. That's at least how I look at it.
Licensed analysts catching on?
Takes time for the buzz to spread.
Curious why that news/ buzz would create an eod bump in ADNA when it cane out early in the day.
Possible social media buzz speculating about Bavarian Nordic (BVNRY) making a production deal with another company to make more of its vaccine for which the FDA has bestowed its approval for emergency use in the US.
What happened eod?
Followers
|
221
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
58917
|
Created
|
02/20/08
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |